R
30.21
0.51 (1.72%)
| 前收盘价格 | 29.70 |
| 收盘价格 | 29.56 |
| 成交量 | 597,589 |
| 平均成交量 (3个月) | 349,431 |
| 市值 | 751,356,736 |
| 价格/销量 (P/S) | 411.22 |
| 股市价格/股市净资产 (P/B) | 5.89 |
| 52周波幅 | |
| 利润日期 | 13 Nov 2025 |
| 稀释每股收益 (EPS TTM) | -19.84 |
| 总债务/股东权益 (D/E MRQ) | 2.16% |
| 流动比率 (MRQ) | 21.11 |
| 营业现金流 (OCF TTM) | -108.63 M |
| 杠杆自由现金流 (LFCF TTM) | -65.95 M |
| 资产报酬率 (ROA TTM) | -44.72% |
| 股东权益报酬率 (ROE TTM) | -75.60% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | RAPT Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
2.1
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 2.13 |
|
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.42% |
| 机构持股比例 | 99.41% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 72.00 (HC Wainwright & Co., 138.33%) | 购买 |
| 72.00 (Wells Fargo, 138.33%) | 购买 | |
| 中 | 60.00 (98.61%) | |
| 低 | 37.00 (Leerink Partners, 22.48%) | 购买 |
| 平均值 | 60.57 (100.50%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 29.67 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JP Morgan | 12 Nov 2025 | 57.00 (88.68%) | 购买 | 29.40 |
| 20 Oct 2025 | 55.00 (82.06%) | 购买 | 33.67 | |
| Barclays | 07 Nov 2025 | 56.00 (85.37%) | 购买 | 28.86 |
| 21 Oct 2025 | 58.00 (91.99%) | 购买 | 33.53 | |
| Wells Fargo | 03 Nov 2025 | 72.00 (138.33%) | 购买 | 29.35 |
| 21 Oct 2025 | 48.00 (58.89%) | 购买 | 33.53 | |
| Guggenheim | 27 Oct 2025 | 70.00 (131.71%) | 购买 | 30.10 |
| HC Wainwright & Co. | 27 Oct 2025 | 72.00 (138.33%) | 购买 | 30.10 |
| Clear Street | 21 Oct 2025 | 60.00 (98.61%) | 购买 | 33.53 |
| 30 Sep 2025 | 41.00 (35.72%) | 购买 | 25.79 | |
| Leerink Partners | 26 Sep 2025 | 37.00 (22.48%) | 购买 | 26.38 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合